Macronix International Co., Ltd.

TWSE:2337 Stock Report

Market Cap: NT$40.0b

Macronix International Balance Sheet Health

Financial Health criteria checks 3/6

Macronix International has a total shareholder equity of NT$45.6B and total debt of NT$24.3B, which brings its debt-to-equity ratio to 53.3%. Its total assets and total liabilities are NT$78.8B and NT$33.2B respectively.

Key information

53.3%

Debt to equity ratio

NT$24.29b

Debt

Interest coverage ration/a
CashNT$10.22b
EquityNT$45.60b
Total liabilitiesNT$33.23b
Total assetsNT$78.83b

Recent financial health updates

Recent updates

Macronix International Co., Ltd.'s (TWSE:2337) Share Price Is Matching Sentiment Around Its Revenues

Oct 28
Macronix International Co., Ltd.'s (TWSE:2337) Share Price Is Matching Sentiment Around Its Revenues

Macronix International Co., Ltd. (TWSE:2337) Analysts Are Pretty Bullish On The Stock After Recent Results

Aug 04
Macronix International Co., Ltd. (TWSE:2337) Analysts Are Pretty Bullish On The Stock After Recent Results

Is Macronix International (TWSE:2337) A Risky Investment?

Jul 19
Is Macronix International (TWSE:2337) A Risky Investment?

Macronix International's (TWSE:2337) Dividend Will Be Reduced To NT$0.50

Jun 13
Macronix International's (TWSE:2337) Dividend Will Be Reduced To NT$0.50

Macronix International Co., Ltd.'s (TWSE:2337) Business And Shares Still Trailing The Industry

Jun 04
Macronix International Co., Ltd.'s (TWSE:2337) Business And Shares Still Trailing The Industry

Is Macronix International Co., Ltd. (TPE:2337) The Right Choice For A Smart Dividend Investor?

Apr 11
Is Macronix International Co., Ltd. (TPE:2337) The Right Choice For A Smart Dividend Investor?

Does Macronix International (TPE:2337) Have A Healthy Balance Sheet?

Mar 22
Does Macronix International (TPE:2337) Have A Healthy Balance Sheet?

Will Macronix International's (TPE:2337) Growth In ROCE Persist?

Mar 06
Will Macronix International's (TPE:2337) Growth In ROCE Persist?

Financial Position Analysis

Short Term Liabilities: 2337's short term assets (NT$29.6B) exceed its short term liabilities (NT$10.4B).

Long Term Liabilities: 2337's short term assets (NT$29.6B) exceed its long term liabilities (NT$22.9B).


Debt to Equity History and Analysis

Debt Level: 2337's net debt to equity ratio (30.9%) is considered satisfactory.

Reducing Debt: 2337's debt to equity ratio has increased from 47.1% to 53.3% over the past 5 years.

Debt Coverage: 2337's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 2337's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies